| P2093 | author name string | Luigi Gennari | |
| | Francesco Dotta | |
| | Ranuccio Nuti | |
| | Daniela Merlotti | |
| | Aurora Patti | |
| P2860 | cites work | Endocrine regulation of energy metabolism by the skeleton | Q22337453 |
| | Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition | Q24629773 |
| | Association between serum osteocalcin and markers of metabolic phenotype | Q24644655 |
| | The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects | Q28263140 |
| | Relationship between osteocalcin and glucose metabolism in postmenopausal women | Q28288662 |
| | Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men | Q28303182 |
| | Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation | Q28575678 |
| | Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone | Q28646319 |
| | Osteocalcin protein sequences of Neanderthals and modern primates | Q28769988 |
| | Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism | Q34021680 |
| | Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome | Q34129927 |
| | Pathogenesis of bone fragility in women and men. | Q34131375 |
| | Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance | Q34137882 |
| | Endocrine regulation of male fertility by the skeleton | Q34642934 |
| | Cross-sectional evidence of a signaling pathway from bone homeostasis to glucose metabolism | Q35001847 |
| | Osteocalcin: a pivotal mediator or an innocent bystander in energy metabolism? | Q35025454 |
| | Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with beta-cell function | Q35101774 |
| | Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice | Q35235417 |
| | Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). | Q35597885 |
| | The role of osteocalcin in human glucose metabolism: marker or mediator? | Q35636353 |
| | Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. | Q35831144 |
| | Relationship of testosterone and osteocalcin levels during growth | Q35832494 |
| | Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults | Q36354495 |
| | Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. | Q36357864 |
| | Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis | Q36438740 |
| | Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice | Q36516140 |
| | Vitamin K-dependent carboxylation of osteocalcin: friend or foe? | Q36828712 |
| | Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism | Q36850959 |
| | Determinants of vitamin K status in humans | Q37122085 |
| | Gamma-carboxylation of osteocalcin and insulin resistance in older men and women | Q37388026 |
| | Effect of physical activity on calcium homeostasis and calciotropic hormones: a review | Q37598618 |
| | Mechanisms of impaired bone strength in type 1 and 2 diabetes | Q37799142 |
| | The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism | Q37866694 |
| | Molecular modulation of osteocalcin and its relevance in diabetes (Review). | Q37880639 |
| | Regulation of glucose metabolism and the skeleton | Q37882008 |
| | Novel functions for insulin in bone | Q37896963 |
| | Vitamin D and diabetes: its importance for beta cell and immune function | Q37926051 |
| | The contribution of bone to whole-organism physiology | Q37977006 |
| | The endocrine role of the skeleton: background and clinical evidence | Q37995795 |
| | Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies | Q38004818 |
| | Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study | Q38475844 |
| | Osteocalcin is associated with testosterone in the general population and selected patients with bone disorders | Q39486114 |
| | A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort | Q39707660 |
| | Increased bone formation in osteocalcin-deficient mice. | Q41182577 |
| | Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants | Q41430454 |
| | The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell line | Q41758759 |
| | Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: a placebo-controlled trial | Q42874813 |
| | Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels | Q43054615 |
| | Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials. | Q43461322 |
| | Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes | Q43510973 |
| | Serum osteocalcin levels are useful as a predictor of cardiovascular events in maintenance hemodialysis patients | Q44170370 |
| | Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients | Q44552901 |
| | Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. | Q44683819 |
| | Knock-in of nuclear localised beta-galactosidase reveals that the tyrosine phosphatase Ptprv is specifically expressed in cells of the bone collar. | Q44813468 |
| | Cloning of hOST-PTP: the only example of a protein-tyrosine-phosphatase the function of which has been lost between rodent and human. | Q45052360 |
| | Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus | Q45332136 |
| | Type 2 diabetes mellitus and testosterone: a meta-analysis study. | Q45921938 |
| | Post-menopausal women with rheumatoid arthritis who are treated with raloxifene or alendronate or glucocorticoids have lower serum undercarboxylated osteocalcin levels | Q46064781 |
| | Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus | Q46264486 |
| | Osteocalcin as a predictor of the metabolic syndrome in older persons: a population-based study. | Q46480326 |
| | Osteocalcin and vitamin D status are inversely associated with homeostatic model assessment of insulin resistance in Canadian Aboriginal and white women: the First Nations Bone Health Study | Q46586962 |
| | Higher serum osteocalcin is associated with lower abdominal aortic calcification progression and longer 10-year survival in elderly men of the MINOS cohort. | Q51345106 |
| | Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and β cell function in elderly men at high cardiovascular risk. | Q51363958 |
| | Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women. | Q51364827 |
| | Osteoid osteoma is an osteocalcinoma affecting glucose metabolism. | Q51371881 |
| | Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men. | Q51374416 |
| | Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes. | Q51383721 |
| | Osteocalcin as a marker of metabolic risk in healthy postmenopausal women. | Q51383907 |
| | Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. | Q51406314 |
| | The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. | Q51439207 |
| | Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. | Q52235837 |
| | Associations of total osteocalcin with all-cause and cardiovascular mortality in older men. The Health In Men Study | Q57313042 |
| | Glucose transport in osteoblast-enriched bone explants: characterization and insulin regulation | Q69051334 |
| | Characterization of the effect of insulin on collagen synthesis in fetal rat bone | Q69880526 |
| | Chemotactic activity of the gamma-carboxyglutamic acid containing protein in bone | Q70986432 |
| | The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants | Q73531419 |
| | A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance | Q77652485 |
| | Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey | Q83480169 |
| | Serum concentrations of osteocalcin, procollagen type 1 N-terminal propeptide and beta-CrossLaps in obese subjects with varying degrees of glucose tolerance | Q83972821 |
| | Risk of newly diagnosed type 2 diabetes is reduced in users of alendronate | Q84459192 |
| | Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis | Q84703100 |
| | The effect of acute exercise on undercarboxylated osteocalcin in obese men | Q84794139 |
| | Osteocalcin: a novel vascular metabolic and osteoinductive factor? | Q84944654 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | osteocalcin | Q59250722 |
| P304 | page(s) | 846480 | |
| P577 | publication date | 2013-04-30 | |
| P1433 | published in | International journal of endocrinology | Q26842119 |
| P1476 | title | Endocrine actions of osteocalcin | |
| P478 | volume | 2013 | |